evenfolioETF Details
T. Rowe Price·Health·TMED · Nasdaq
T. Rowe Price Health Care ETF (TMED)
- Price
- $33.94
- —25 Sept 2026
- Assets
- $31.9M
- Total net assets
- Expense ratio
- 0.44%
- Category 1.00%
- Yield
- 0.46%
- Trailing distributions
- 1Y return
- 33.4%-2.6%
- Category 36.0%
- 3Y CAGR
- —
- Category 16.5%
- 5Y CAGR
- —
- Category 2.9%
Loading NAV history…
T. Rowe Price Health Care ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | -6.2% | -0.6% | +22.7% | +14.2% | +33.4% | — | — | — | +26.8% |
| Health average | -3.2% | 5.9% | 25.6% | 16.1% | 36.0% | 16.5% | 2.9% | 9.1% | 11.4% |
| Difference | -3.0% | -6.6% | -2.9% | -1.9% | -2.6% | — | — | — | +15.4% |
Holdings
The 10 largest positions make up 46.1% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| LLY | Eli Lilly and Co | 14.02% |
| UNH | UnitedHealth Group Inc | 5.33% |
| ALNY | Alnylam Pharmaceuticals Inc | 5.20% |
| TMO | Thermo Fisher Scientific Inc | 3.74% |
| COR | Cencora Inc | 3.65% |
| PODD | Insulet Corp | 3.23% |
| GILD | Gilead Sciences Inc | 3.00% |
| A | Agilent Technologies Inc | 2.85% |
| ELAN | Elanco Animal Health Inc | 2.64% |
| DYN | Dyne Therapeutics Inc Ordinary Shares | 2.47% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 32.4
- P/B
- 4.7
- P/S
- 1.6
- P/CF
- 22.2
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.3%
- Cash0.7%
ETF details
- Issuer
- T. Rowe Price
- Category
- Equity · Health
- Ticker
- TMED
- Exchange
- Nasdaq
- Inception
- 11 Jun 2025 (1.3 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.44% (category 1.00%)
- Holdings turnover
- 44% (category 51%)
- Distribution yield
- 0.46%
- Beta, 3 years
- 0.00
- Total net assets
- $31.9M
Prices and returns as of 25 Sept 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- HELX · Franklin Genomic Advancements ETFFranklin Templeton, Inc · $31.5M · ER 0.50%5Y -4.6%
- HEAL · Global X HealthTech ETFGlobal X Funds · $31.2M · ER 0.50%5Y -11.7%
- GDOC · Future Health Care Equity ETFGoldman Sachs · $19.6M · ER 0.75%
- MEDX · Horizon Kinetics Medical ETFHorizon Kinetics · $17.1M · ER 0.85%
- JDOC · JPMorgan Healthcare Leaders ETFJPMorgan · $9.4M · ER 0.65%
- IBRN · iShares Neuroscience and Healthcare ETFiShares · $7.8M · ER 0.47%